MEC Plus Full List ViewBy pinki@katapult.biz / February 16, 2025 MEC Plus Speciality — Amyotrophic Lateral Sclerosis (ALS) Biomarkers Biosimilars Bladder Blood Bone Brain Breast Cancer Central Nervous System (CNS) Clinical Trials Colon Colorectal Diversity, Equity & Inclusion Featured Content Gastrointestinal Genitourinary Genomic Geriatric Gynecology Head and Neck Hematologic Hematologic Maglinencies Hematology Immunotherapy Interventional Radiology Kidney Leukemia Liquid Biopsy Liver Lung Lymphoma Malignant Malignencies Melanoma Myelodysplastic Syndrome Myeloma Neuroendocrine Novel Oral & Maxillofacial Surgery Oral Cancer Ovarian Pancreas Pancreatic Pharmacological Prostate Radiation Radiology Renal Sarcoma Skin Solid Tumor Supportive & Palliative Care Survivorship Telemedicine Thoracic Thrombosis Thymic Thyroid Urothelial Author / Speaker Title Type of Media — Video Document Audio Events — 2024 California Cancer Consortium Conference (CCC) 2024 MCM 2024 MCM 2024 MLS Cleveland 2024 MLS Nashville 2024 MLS New Orleans 2024 MLS Seattle 2024 New Orleans Summer Cancer Meeting (NOSCM) 2024 PRIMO 2024 SPS Puerto Rico 2024 SPS Seattle 2024 SPECTRUM 2024 Sylvester APP Oncology Symposium 2024 WCS 2024 MaTOS Lungs 2025 PRIMO Search Everything « 1 … 77 78 79 80 81 … 96 » The Future of Targeted Therapy in Lung Cancer Pasi A. Janne, MD, PhD View PDF Updates in Immunotherapy for Lung Cancer: Integration of Predictive Biomarkers David R. Gandara, MD View PDF Progress in CAR-T Cell Therapies Stephen J. Forman, MD View PDF Esophageal and Gastric Cancer: New Developments George A. Fisher, MD, PhD View PDF State of the Art: Hormone-sensitive Prostate Cancer Tanya Dorff, MD View PDF How I Treat Advanced Head and Neck Cancer A. Dimitrios Colevas, MD View PDF Pancreatic Cancer: Emerging Strategies Vincent Chung, MD, FACP View PDF Advances in Metastatic Breast Cancer Mili Arora, MD View PDF Lung Targeted Therapies IN NSCLC: EGFR, ALK, and ROS1 Edgardo S. Santos, MD, FACP View PDF Lung Targeted Therapies in NSCLC: RET, MET and EGFR/HER-2 exon 20 Robert Ramirez, DO, FACP View PDF Immunotherapy in Lung Luis E. Raez, MD, FACP, FCCP View PDF Immunotherapy & Targeted Therapy in Melanoma Sanjiv Agarwala, MD View PDF Breast Targeted Therapy: HER2, CDK 4/6, PI3KCA Mark Pegram, MD View PDF Immunotherapy in Breast Alberto Montero, MD, MBA, CPHQ View PDF Immunotherapy in Kidney & Bladder Pedro Barata, MD, MSc View PDF Targeted Therapy in Prostate Ulka Vaishampayan, MD View PDF Gastric, Esophagael, and Circulating Tumor Cells in GI Cancers Pashtoon Kasi, MD, MS View PDF Small cell and Squamous Cell Lung Cancer Update Goetz Kloecker, MD MSPH MBA FACP View PDF Lung Adenocarcinoma Updates Melissa L. Johnson, MD View PDF Breast Cancer Update in Triple Negative and HER2 Breast Cancers Stephanie L. Graff, MD View PDF Breast Cancer Update in Hormone Sensitive Breast Cancer Ingrid Mayer, MD View PDF Drug Brown and White Bagging: What is It and Where Does it Lead Us? Jorge J. García, PharmD, MS, MHA, MBA, FACHE View PDF Melanoma and Skin Cancer Updates Meredith McKean, MD View PDF Prostate and Bladder Cancer Updates Guru P. Sonpavde, MD View PDF Renal Cell Cancer Updates Brian Rini, MD View PDF CRC Updates Cathy Eng, MD View PDF Biosimilars as Front-Line Options for Cancer Care Jorge J. García, PharmD, MS, MHA, MBA, FACHE View PDF Parp Inhibitors and Chemotherapy for Breast Cancer D. Constanza Guaqueta, MD View PDF Hormonal Therapy in Breast Cancer Alberto Montero, MD, MBA, CPHQ View PDF HER2-Driven Breast Cancer: Current Status and Next Generation Therapeutics Otto Metzger, MD View PDF
